Company news
HCW Biologics Inc. news in 2022
HCW Biologics Inc.'s news releases, calls and decks from 2022, newest first.
HCW Biologics Enters CRADA with National Cancer Institute
December 7, 2022
HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform
December 6, 2022
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting
November 7, 2022
HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights
November 6, 2022
HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights
August 11, 2022
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
August 2, 2022
HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
May 22, 2022
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 12, 2022
HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists
May 4, 2022
HCW Biologics’ CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022
April 18, 2022
HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021
March 27, 2022
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
March 23, 2022
Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics’ Novel Bifunctional Fusion Protein
January 23, 2022
HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens
January 19, 2022
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Participating in Cambridge Healthtech Institute’s Annual PepTalk Conference 2022
January 18, 2022
HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 – 13, 2022
January 5, 2022